[ARWR] YoY Quarter Result on 30-Sep-2017 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
12-Dec-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q4]
Profit Trend
QoQ- -94.42%
YoY- 51.71%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 7,633 43,293 11,255 8,714 31 44 44 135.97%
PBT -48,430 11,878 -10,759 -10,729 -22,220 -24,741 -22,425 13.67%
Tax 2 174 2 2 2 2 5 -14.15%
NP -48,433 11,705 -10,761 -10,732 -22,222 -24,743 -22,430 13.67%
Tax Rate - -1.46% - - - - - -
Total Cost 56,066 31,588 22,016 19,446 22,253 24,787 22,474 16.44%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -634.53 27.04 -95.61 -123.16 -71,110.36 -56,555.74 -51,269.58 -51.87%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.47 0.12 -0.12 -0.14 -0.31 -0.42 -0.42 1.89%
EPS Diluted -0.47 0.12 -0.11 -0.14 -0.31 -0.42 -0.41 2.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.